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Antibody Responses of Young Calves to Inactivated Viral Vaccines
Abstract
Three commercial inactivated virus vaccines were evaluated for immunogenicity in young calves with residual
maternal antibodies. Groups of 30 calves were administered each of the vaccines at the start of the
experimentation and were administered a second dose 32 days later. Serum was obtained from these calves
and 30 calves in a nonvaccinated control group prior to vaccination and at 32, 61, 99 and 125 days thereafter.
Antibody responses to viruses in two of the vaccines were extremely limited. The third vaccine overcame
suppression by maternal antibodies and elicited responses clearly differentiated from antibody levels in the
control group of calves.
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Summary
Three commercial inactivated virus vaccines were
evaluated for immunogenicity in young calves with
residual maternal antibodies.  Groups of 30 calves were
administered each of the vaccines at the start of the
experimentation and were administered a second dose
32 days later.  Serum was obtained from these calves
and 30 calves in a nonvaccinated control group prior to
vaccination and at 32, 61, 99 and 125 days thereafter.
Antibody responses to viruses in two of the vaccines
were extremely limited.  The third vaccine overcame
suppression by maternal antibodies and elicited
responses clearly differentiated from antibody levels in
the control group of calves.
Introduction
A number of viruses including bovine viral diarrhea
(BVD), infectious bovine rhinotracheitis (IBR),
parainfluenza type 3 (PI-3), and bovine respiratory syncytial
(BRS) virus are ubiquitous   in our cattle population.
Consequently, cows in most herds possess antibodies to
these viruses either as a result of natural infection or
vaccination.  These antibodies are transferred to a newborn
calf by ingestion of colostrum and may protect the calf from
infection during early life.
While these maternal antibodies may be protective, they
also may interfere with induction of acquired immunity by
vaccination.  This interference relates directly to the level of
antibodies in the vaccinated calf.  The level of antibodies
among calves in a herd may be extremely variable, and this
situation contributes to a major problem.  Many calves
cannot be effectively immunized at a time when other calves
are susceptible to natural infection.
Commercial vaccines available for immunization of cattle
contain either modified-live or inactivated viruses.  Maternal
antibodies may interfere with induction of immunity by
either type of vaccine.  Modified-live virus vaccines have
been reported to be particularly susceptible to antibody
interference.  There are recent indications that appropriately
formulated inactivated vaccines may be effective in inducing
active immunity even in the presence of maternal antibodies.
The objective of this experimentation was to evaluate the
immunogenicity of three commercial inactivated virus
vaccines in young calves with residual maternal antibodies.
Materials and Methods
One hundred twenty calves in the Rhodes Farm Research
beef herd were selected and randomly assigned to one of four
groups of 30 animals each.  These calves were of mixed
breeding, born in the Spring of 1995, and ranged in age
from 28 to 69 days at the time of primary vaccination.
At the start of the experimentation the calves were bled
for serum, and calves in treatment groups were administered
a commercial vaccine.  All vaccines contained inactivated
IBR, BVD, PI-3 and BRS viruses and were purchased from
Midwest Veterinary Supply, Des Moines, Iowa.  The 5 ml
dose of each vaccine was injected into two sites, 2.5 ml
intramuscularly in each thigh.  Groups and vaccine
administered were as follows:
Group A -- Controls, no vaccination
Group B --  ELITE 4, Boerhinger Ingelheim Animal
Health, Inc., St. Joseph, Missouri
Group C -- Triangle 4, Ft. Dodge Laboratories, Inc.,
Fort Dodge, Iowa
Group D -- Vira Shield 5, Grand Laboratories, Inc.,
Larchwood, Iowa
     Calves were bled and administered a second dose of the
vaccine 32 days later.  They were bled again on days 61, 99
and 125 of the experimentation.
Serum was harvested and stored at -20°C until tested for
antibodies to the various viruses.  Antibody titers were
determined by standard microtiter virus neutralization tests
conducted with two-fold dilutions of serum.
Table 1. Serum antibody titers to various viruses for all 120
calves at the time of primary vaccination.
  IBR    BVD-1*    BVD-2**    PI-3    BRS
Mean Titer 12.6 155.0 69.3 86.3 40.8
Range of Ü2-128 20-1,920 7.5-1,280 2.75-480 Ü2-480
  Titers
   *Biotype 1
 **Biotype 2
Results and Discussion
At the start of the experimentation almost all the calves
had detectable antibodies against each of the viruses, but
titers were quite variable among the animals (Table 1).  The
level of residual maternal antibodies was highest to BVD
biotype 1 virus and lowest to IBR virus.  The presence of
detectable antibodies in the serum of most of the calves at
this time is an important consideration because there was
potential for interference with the vaccines.
Mean antibody responses to IBR virus, BVD virus
biotype 1, BVD virus biotype 2, and PI-3 virus in the four
groups of calves are presented in Figures 1, 2, 3 and 4,
respectively.  As expected, antibody titers to each of the
viruses declined in the control calves during the period of
experimentation.  This supports clinical observations of no
respiratory disease in these animals during the experiment
and absence of natural infection with any of the viruses.
Thirty days following primary vaccination mean antibody
titers to all viruses had declined in all groups of calves
indicating minimal, if any, humoral response to the
vaccines.  By 61 days vaccination effects were apparent in
some groups of calves.  Responses to the IBR component
(Figure 1) were somewhat disappointing, but each of the
vaccines seemed to have elicited a response in some calves
at this time.  However, the responses of Group D calves was
appreciably better and this effect continued for the duration of
the experiment.
Residual maternal antibody titers to BVD virus were
high in the calves at the time of primary vaccination and
probably influenced the response to the vaccines.  As
compared with the Group A controls, little if any response
was elicited in Group B calves (Figures 2 and 3).  Antibody
titers to BVD biotype 1 virus in Group C calves at 61 days
indicated some response, but the response did not persist
(Figure 2).  Also, Group C calves failed to respond with an
increase in antibody titers to BVD biotype 2 virus (Figure
3).  In contrast, the response of Group D calves to both
biotypes of BVD virus was clearly discernible at 61 days,
and antibody levels remained high during the experimental
period.
Maternal antibody levels to PI-3 virus were quite high at
the beginning of the experiment.  Although there appeared
to be a response in some animals in each of the vaccinated
groups, mean antibody levels in Groups B and C were
essentially equivalent to the Group A controls at the
termination of the experiment (Figure 4).  Mean antibody
levels in Group D calves were higher than any other group
on day 61, and this difference persisted  throughout the
experimental period.
This experimentation demonstrated that appropriately
formulated inactivated virus vaccines do have the potential
to overcome suppression by maternal antibodies and induce
acquired humoral immunity in young calves.  In particular,
the Vira Shield 5 vaccine produced by Grand Laboratories
induced clearly differentiated antibody responses 61 days
following primary immunization which persisted through
the following 60 days.  The vaccine apparently
overwhelmed suppression by moderate levels of maternal
antibodies.  This was clearly demonstrated in the case of
BVD virus.  Furthermore, the response was elicited to both
biotypes of the virus.
Implications
This experimentation demonstrated that a commercial,
inactivated virus vaccine can overcome suppression by
maternal antibodies to induce an acquired antibody
response.  These findings are particularly interesting since
they may indicate that young calves can be successfully
immunized against several viruses that commonly infect
young cattle.
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Figure 1. Mean antibody titers to IBR virus in four groups of calves. Calves were left as unvaccinated controls (A) or were
vaccinated with one of three commercial inactivated virus vaccines (B,C,D) on days 0 and 32.
Figure 2. Mean antibody titers to BVD biotype 1 virus in four groups of calves. Calves were left as unvaccinated controls (A) or
were vaccinated with one of three commercial inactivated virus vaccines (B,C,D) on days 0 and 32.
Figure 3. Mean antibody titers to BVD biotype 2 virus in four groups of calves. Calves were left as unvaccinated controls (A) or
were vaccinated with one of three commercial inactivated virus vaccines (B,C,D) on days 0 and 32.
Figure 4. Mean antibody titers to PI-3 virus in four groups of calves. Calves were left as unvaccinated controls (A) or were
vaccinated with one of three commercial inactivated virus vaccines (B,C,D) on days 0 and 32.
